Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis
- PMID: 35699351
- PMCID: PMC10029827
- DOI: 10.1002/jso.26972
Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis
Abstract
Background: Diagnostic laparoscopy (DL) is a key component of staging for locally advanced gastric adenocarcinoma (GA). We hypothesized that utilization of DL varied between safety net (SNH) and affiliated tertiary referral centers (TRCs).
Methods: Patients diagnosed with primary GA eligible for DL were identified from the US Safety Net Collaborative database (2012-2014). Clinicopathologic factors were analyzed for association with use of DL and findings on DL. Overall survival (OS) was analyzed by Kaplan-Meier method.
Results: Among 233 eligible patients, 69 (30%) received DL, of which 24 (35%) were positive for metastatic disease. Forty percent of eligible SNH patients underwent DL compared to 21.5% at TRCs. Lack of insurance was significantly associated with decreased use of DL (OR 0.48, p < 0.01), while African American (OR 6.87, p = 0.02) and Asian race (OR 3.12, p ≤ 0.01), signet ring cells on biopsy (OR 3.14, p < 0.01), and distal tumors (OR 1.62, p < 0.01) were associated with increased use. Median OS of patients with a negative DL was better than those without DL or a positive DL (not reached vs. 32 vs. 12 months, p < 0.005, Figure 1).
Conclusions: Results from DL are a strong predictor of OS in GA; however, the procedure is underutilized. Patients from racial minority groups were more likely to undergo DL, which likely accounts for higher DL rates among SNH patients.
Keywords: diagnostic laparoscopy; disparities; gastric adenocarcinoma; safety net hospital.
© 2022 Wiley Periodicals LLC.
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Figures
References
-
- Society AC. Cancer Facts & Figures 2020. 2021. Accessed October 26, 2021. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts...
-
- Rawicz-Pruszyński K, Mielko J, Pudło K, et al. Yield of staging laparoscopy in gastric cancer is influenced by lauren histologic subtype. J Surg Oncol. 2019;120(7):1148–1153. - PubMed
-
- Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101(2):23–31. - PubMed
-
- Ajani JA, D’Amico TA, Almhannav K. NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer. 2021. Accessed October 26, 2021. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf